Is There a Link Between Myeloma and Dental Health? from Patient Empowerment Network on Vimeo. Dr. Sikander Ailawadhi from Mayo Clinic explains that while multiple myeloma doesn’t commonly cause dental […]
Bone-Building Therapies Recommended for Myeloma Patients from Patient Empowerment Network on Vimeo. What can multiple myeloma patients do for bone-building therapies? Dr. Sikander Ailawadhi from the Mayo Clinic discusses bone-strengthening […]
Are Fluctuations in Light Chain Values Common in Myeloma Remission? from Patient Empowerment Network on Vimeo. Myeloma remission may bring changes in light chain values, but how often do these […]
Is Monosomy 13 a High-Risk Marker for Myeloma? from Patient Empowerment Network on Vimeo. High-risk multiple myeloma has some markers, but is monosomy 13 one of these markers? Dr. Sikander […]
What Are Some Clinical Myeloma Relapse Predictors? from Patient Empowerment Network on Vimeo. Some multiple myeloma patients may relapse, but are there clinical predictors for relapse? Dr. Sikander Ailawadhi from […]
Why Do Some Myeloma Patients Experience Chronic Kidney Disease? from Patient Empowerment Network on Vimeo. What do multiple myeloma patients need to know about chronic kidney disease? Dr. Sikander Ailawadhi […]
Myeloma Patient Expert Q&A: Start Here from Patient Empowerment Network on Vimeo. In this myeloma patient expert Q&A, Mayo Clinic expert Dr. Sikander Ailawadhi provides highlights around the myeloma novel […]
Last week we hosted a “Let’s Talk Toxic Positivity” Empowered #patientchat on Twitter. Take a look at the top tweets and full transcript from the chat. Top Tweets Toxic positivity […]
What AML Mutations Are Associated With Adverse Outcomes? from Patient Empowerment Network on Vimeo. Which acute myeloid leukemia (AML) mutations are linked to adverse outcomes? Dr. Naval Daver from the […]
BIPOC Patients Living With AML | Mortality Rate and Favorable Genetics from Patient Empowerment Network on Vimeo. How can acute myeloid leukemia (AML) disparities be addressed in BIPOC groups? Dr. […]
Challenges in Treating TP53-Mutated AML, Hope on the Horizon from Patient Empowerment Network on Vimeo. TP53-mutated acute myeloid leukemia (AML) treatment has some challenges. Dr. Naval Daver from the University […]
A Look at Ongoing Acute Myeloid Leukemia Phase III Trials from Patient Empowerment Network on Vimeo. What are the acute myeloid leukemia (AML) Phase III clinical trials that are ongoing? […]
What Does Triplet Therapy in AML Mean for the Future? from Patient Empowerment Network on Vimeo. What do acute myeloid leukemia (AML) patients need to know about triplet therapy? Dr. […]
A Look at Lower Intensity Chemotherapy in Untreated AML from Patient Empowerment Network on Vimeo. Dr. Naval Daver from the University of Texas MD Anderson Cancer Center discusses whether untreated acute […]
AML Clinical Trials Critical to Treatment Breakthroughs and Improvements from Patient Empowerment Network on Vimeo. Why are acute myeloid leukemia (AML) clinical trials so critical? Dr. Naval Daver from the […]
